Associate Director, TMF Lead

Job not on LinkedIn

🔥 0 minutes ago

Apply Now

Find Similar Remote Jobs

Set Up Email Alert For New Jobs

📊 Check your resume score for this job

Improve your chances of getting an interview by checking your resume score before you apply.

Upload Resume

Kyverna Therapeutics

WebsiteLinkedInAll Job Openings

51 - 200 employees

Founded 2019

🧬 Biotechnology

💊 Pharmaceuticals

🔬 Science

💰 $85M Series B on 2022-01

Biotechnology • Pharmaceuticals • Science

Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.

📋 Description

• Lead the end-to-end TMF strategy, including the transition from outsourced to in-house operations, ensuring control, scalability, and quality across all clinical studies. • Define and implement TMF governance, processes, and standards to ensure consistent document organization, classification, and filing in alignment with regulatory requirements and industry best practices. • Serve as the TMF subject matter expert, establishing clear expectations for document structure, naming conventions, indexing, and lifecycle management. • In partnership with Clinical Operations study lead, oversee TMF health across all studies, ensuring completeness, accuracy, and inspection readiness at all times through ongoing quality control and reconciliation. • Lead TMF activities across the study lifecycle, including study start-up, maintenance, and close-out, ensuring proper documentation, completeness reviews, and archival readiness. • Own and execute TMF migration efforts ensuring data integrity, completeness, and alignment with Kyverna standards. • Assess and evaluate TMF system providers by defining requirements, conducting vendor assessments, and leading cross-functional reviews to identify a compliant, scalable, and inspection-ready solution. • Partner closely with Clinical Operations, Clinical Development, Regulatory, Quality, IT and external partners to ensure seamless document flow and accountability. • Operate comfortably in both strategy and execution, including direct involvement in document review, filing quality, and issue resolution. • Establish TMF metrics and KPIs to proactively identify risks, drive continuous improvement, and ensure sustained inspection readiness. • Support regulatory inspections and audits as the TMF lead, ensuring readiness and effective responses to health authority inquiries.

🎯 Requirements

• Bachelor’s degree in life sciences or related field; advanced degree preferred. • 10+ years of clinical research experience with a strong focus on TMF management. • Proven experience leading TMF operations, including both strategic oversight and hands-on execution. • Demonstrated experience transitioning TMF activities from outsourced to in-house models. • Strong expertise in Veeva Vault eTMF, including implementation, migration, and ongoing management. • Deep understanding of TMF structure, document taxonomy, and regulatory requirements (FDA, EMA, ICH-GCP). • Experience managing TMF across the full study lifecycle, including close-out and archival. • Experience leading TMF migration initiatives with a focus on quality and compliance. • Experience in biotech or cell and gene therapy. • Experience supporting regulatory inspections and audits. • Experience building or scaling TMF capabilities within a growing organization.

🏖️ Benefits

• Bonus • Benefits • Participation in Company’s stock plan